| [1] |
HAN Chao, KONG Weimin, SONG Dan.
Overexpression of miR-130a-3p enhances chemoradiotherapy sensitivity of human cervical cancer cell line Caski
[J]. Basic & Clinical Medicine, 2026, 46(8): 1103-1108.
|
| [2] |
CHEN Weixin.
Analysis of the immune characteristics of peripheral blood lymphocyte subsets in patients with early and advanced non-small cell lung cancer
[J]. Basic & Clinical Medicine, 2026, 46(6): 823-829.
|
| [3] |
LIU Pengpeng, SUN Zhao, QIU Wei, TANG Hui, ZHU Wenjia, WANG Wenhui, WANG Yingyi.
Impact of local radiotherapy on tyrosine kinase inhibitor treatment in non-small cell lung cancer with oligo-residual disease
[J]. Basic & Clinical Medicine, 2026, 46(4): 491-497.
|
| [4] |
ZHANG Zhen, YANG Lianren, HU Junkun, ZHANG Wei, LIANG Wei.
Value of serum D-dimer in evaluating chemotherapy effect and prognosis in patients with non-small cell lung cancer
[J]. Basic & Clinical Medicine, 2026, 46(3): 417-420.
|
| [5] |
YIN Jie, WANG Xue, DENG Shukai.
Effects of disulfiram on proliferation, apoptosis and gefitinib resistance of lung cancer cell line H1975
[J]. Basic & Clinical Medicine, 2026, 46(10): 1352-1358.
|
| [6] |
LU Wei, WANG Yanmin, LIU Bingchen, TAO Xin, WANG Shipeng, CAO Qiuye.
Berberine enhances the chemotherapy sensitivity of prostate cancer cell line 22RV1 to docetaxel
[J]. Basic & Clinical Medicine, 2026, 46(1): 39-45.
|
| [7] |
CHEN Lei,REN Weihao,WANG Lide.
Knockdown of translocase of inner mitochondrial membrane 8A enhances gefitinib sensitivity to lung cancer cell line PC-9
[J]. Basic & Clinical Medicine, 2025, 45(8): 1073-1077.
|
| [8] |
LOU Haijun, TONG Zhuoyun, ZHANG Zhenyu, Aheyerk·MAHESHATI, MENG·Menggen, WUDU Muli.
Knockdown of DRAM2 inhibits the proliferation and migration of lung cancer cell line A549
[J]. Basic & Clinical Medicine, 2025, 45(2): 197-202.
|
| [9] |
LIU Qi, NIE Muwen, ZHANG Jingqi, LI Ningning, ZHAO Lin.
Single-center retrospective analysis of peritoneal mesothelioma
[J]. Basic & Clinical Medicine, 2025, 45(10): 1362-1367.
|
| [10] |
CHEN Qingxia, LIANG Yuling, LUO Yalan, NIU Bin.
Inhibition of NRF1/ABCC1 improves chemosensitivity of human lung adenocarcinoma cell lines to cisplatin
[J]. Basic & Clinical Medicine, 2025, 45(1): 51-59.
|
| [11] |
ZHENG Hong, CHEN Xiaoxia, HAN Lizhou, CHEN Miao, HUANGFU Juan.
Decrease of lncRNA-RMRP expression inhibits proliferation and invasion of human lung cancer cell line A549
[J]. Basic & Clinical Medicine, 2024, 44(7): 974-978.
|
| [12] |
LIANG Xiangcun, WEI Xiaoyu, LIANG Jian, WANG Qing, GENG Guang.
Anlotinib inhibits proliferation and promotes apoptosis of human non-small cell lung cancer cell lines through miR-16-5p/PD-1 axis
[J]. Basic & Clinical Medicine, 2024, 44(4): 503-512.
|
| [13] |
ZHANG Jing, YANG Zigeng, CAI Wenqin, CAO Weiwei, WEI Hongmei, XUE Xixi, WU Bin.
Inhibition of prohibitin 2 enhances the sensitivity of non-small cell lung cancer cell line A549 to erlotinib
[J]. Basic & Clinical Medicine, 2024, 44(3): 325-332.
|
| [14] |
LI Juan, LI Xiaofeng, XU Shengzhi, TANG Kai.
Efficacy of cinobufacini capsule combined with docetaxel plus cisplatin chemotherapy for the treatment of non-small cell lung cancer
[J]. Basic & Clinical Medicine, 2024, 44(2): 247-251.
|
| [15] |
DING Fei, WANG Sa, HUANG Changxin.
Serum CA211 level and NK cell number are associated with prognosis of patients with non-small cell lung cancer
[J]. Basic & Clinical Medicine, 2024, 44(2): 180-184.
|